Anti-angiogenic potential of CoenzymeQ10, riboflavin and niacin in breast cancer patients undergoing tamoxifen therapy (Q46648416)

23 December 2017

title

Anti-angiogenic potential of CoenzymeQ10, riboflavin and niacin in breast cancer patients undergoing tamoxifen therapy (English)

1 reference

23 December 2017

main subject

angiogenesis inhibitor

1 reference

1 reference

1 reference

1 reference

Vummidi Giridhar Premkumar

1

1 reference

23 December 2017

Srinivasan Yuvaraj

2

1 reference

23 December 2017

Sivaprakasam Sathish

3

1 reference

23 December 2017

Palanivel Shanthi

4

1 reference

23 December 2017

Panchanatham Sachdanandam

5

1 reference

23 December 2017

publication date

5 March 2008

1 reference

23 December 2017

published in

Vascular Pharmacology

1 reference

23 December 2017

volume

48

1 reference

23 December 2017

issue

4-6

1 reference

23 December 2017

page(s)

191-201

1 reference

23 December 2017

Endostatin's antiangiogenic signaling network

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Role of elastin in pathologic calcification of xenograft heart valves

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5'-deoxy-5-fluorouridine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Action of tropoelastin and synthetic elastin sequences on vascular tone and on free Ca2+ level in human vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

The biology of VEGF and its receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Survival of cancer patients on therapy with coenzyme Q10.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Activities of vitamin Q10 in animal models and a serious deficiency in patients with cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

What Is the Evidence That Tumors Are Angiogenesis Dependent?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Angiogenesis in cancer, vascular, rheumatoid and other disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Epidermal growth factor receptor (EGFr) expression in non-small cell lung carcinomas correlates with metastatic involvement of hilar and mediastinal lymph nodes in the squamous subtype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Clinical significance of determination of surrogate markers of angiogenesis in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Soluble Forms of Vascular Adhesion Molecules, E‐Selectin, ICAM‐1, and VCAM‐1: Pathological Significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Effects of gefitinib on serum epidermal growth factor receptor and HER2 in patients with advanced non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

The elastin receptor: a galactoside-binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

PGE2: a mediator of corneal endothelial wound repair in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Basement membranes: structure, assembly and role in tumour angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Increased angiogenic response in aortic explants of collagen XVIII/endostatin-null mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Partial and complete regression of breast cancer in patients in relation to dosage of coenzyme Q10

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Progress on therapy of breast cancer with vitamin Q10 and the regression of metastases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Stimulation of DNA synthesis in hepatocytes by hepatocyte growth factor bound to extracellular matrix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Elastin degradation by matrix metalloproteinases. Cleavage site specificity and mechanisms of elastolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Redefining the target: chemotherapeutics as antiangiogenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Signaling pathways transduced through the elastin receptor facilitate proliferation of arterial smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Interleukin-1beta increases expression and activity of matrix metalloproteinase-2 in cardiac microvascular endothelial cells: role of PKCalpha/beta1 and MAPKs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Clinical significance of the expression of epidermal growth factor and its receptor in esophageal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

MMP-2 protein in invasive breast cancer and the impact of MMP-2/TIMP-2 phenotype on overall survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

MMP-2 and MMP-9 activity is regulated by estradiol and tamoxifen in cultured human breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Preparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Critical aspects of the antioxidant function of coenzyme Q in biomembranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

The promise of anti-angiogenic cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Effects of riboflavin deficiency and riboflavin administration on carcinogen-DNA binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Energy-modulating vitamins--a new combinatorial therapy prevents cancer cachexia in rat mammary carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Augmented efficacy of tamoxifen in rat breast tumorigenesis when gavaged along with riboflavin, niacin, and CoQ10: effects on lipid peroxidation and antioxidants in mitochondria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Serum cytokine levels of interleukin-1beta, -6, -8, tumour necrosis factor-alpha and vascular endothelial growth factor in breast cancer patients treated with tamoxifen and supplemented with co-enzyme Q(10), riboflavin and niacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Effect of coenzyme Q10, riboflavin and niacin on serum CEA and CA 15-3 levels in breast cancer patients undergoing tamoxifen therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Interleukin-1 beta increases basic fibroblast growth factor mRNA expression in adult rat brain and organotypic hippocampal cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Differential expression of vascular endothelial growth factor mRNA vs protein isoform expression in human breast cancer and relationship to eIF-4E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA levels in tumor tissues and the efficacy of 5-fluorouracil in patients with non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Riboflavin deficiency and esophageal cancer: a case control-household study in the Caspian Littoral of Iran

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Serum evaluation of basic fibroblast growth factor in cervical cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

The therapeutic potential of poly(ADP-ribose) polymerase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Inhibition of matrix metalloproteinase activity attenuates tenascin-C production and calcification of implanted purified elastin in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Elastin peptide concentration in human serum: variation with antibodies and elastin peptides used for the enzyme-linked immunosorbent assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Niacin prevents DNA strand breakage by adenosine deaminase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

Regulation of MMPs and TIMPs by IL-1beta during corneal ulceration and infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

High serum endostatin levels in Down syndrome: implications for improved treatment and prevention of solid tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2008.02.003

10.1016/J.VPH.2008.02.003

7 January 2021

Identifiers

DOI

1 reference

23 December 2017

PubMed ID

18407793

1 reference

23 December 2017